Ampio Pharmaceuticals
AMPE
#10768
Rank
C$0.28 M
Marketcap
C$0.25
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Earnings for Ampio Pharmaceuticals (AMPE)

Earnings in 2023 (TTM): -C$11.6 Million

According to Ampio Pharmaceuticals's latest financial reports the company's current earnings are N/A. , an increase over its 2022 earnings that were of -C$22.53 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ampio Pharmaceuticals from 2007 to 2023

Annual earnings

Year Earnings Change
2023 -C$11.91 Million-47.14%
2022 -C$22.53 Million-4.36%
2021 -C$23.56 Million7.42%
2020 -C$21.93 Million16.62%
2019 -C$18.81 Million-140.1%
2018 C$46.88 M-165.49%
2017 -C$71.59 Million170.77%
2016 -C$26.44 Million-30.16%
2015 -C$37.86 Million-29.73%
2014 -C$53.87 Million59.2%
2013 -C$33.84 Million111.58%
2012 -C$16 Million-36.57%
2011 -C$25.22 Million127.2%
2010 -C$11.1 Million758.38%
2009 -C$1.3 Million3105.94%
2008 -C$0.05 Million0.79%
2007 -C$0.05 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$35.83 B-301,061.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$14.61 B-122,794.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
C$11.22 B-94,365.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
C$7.11 B-59,841.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Rigel Pharmaceuticals
RIGL
C$0.16 B-1,512.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
-C$0.11 Billion 819.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-C$32.07 Million 169.24%๐Ÿ‡บ๐Ÿ‡ธ USA